CELL_LINE	CHROM	REF	ALT	POS	FILTER	AV_GENESYM	UNIPROT_ID	ENSEMBL_ID	GENE_ID	AV_CONSTYPE	AV_AACHANGE	AV_AACHANGE_PRIMARY	CODON_CHANGE	AV_cDNACHANGE	AV_TRANSCRIPT	DBNSFP_VOTE	DBNSFP	PFAM_DOMAINS	PROSITE	UNIPROT_FEATURES	CANCER_CENSUS	CANCER5000	UP_ONCOGENE	UP_TUMORSUPPRESS	DRUGS_ANTINEOPLASTIC_DGIDB	dbSNPBuildID	dbSNPrsID	CC_FREQ_VAR	CC_FREQ_CODON	CC_FREQ_DOMAIN	CC_FREQ_VAR_SUBTYPE	CC_FREQ_CODON_SUBTYPE	CC_FREQ_DOMAIN_SUBTYPE	TCGA_REC_FREQ	ALLELIC_SUPPORT	SEQ_DEPTH	ALLELIC_FRACTION
A375	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA	1	NA	1	NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	0,189	189	1
A375	chr9	C	A	21971153	PASS	CDKN2A	CD2A1_HUMAN	ENSG00000147889	1029	stop_gained	p.E69X	p.E69X	GAG>TAG	exon2:c.205G>T	NM_001195132,NM_000077	damaging	damaging#.#benign#damaging#.#.	NA	PS50297#ANK_REP_REGION	NA		NA	NA	1	BAY1000394,LEE011,LY2835219,PD_0332991	133	121913383	8	2,182289	NA	NA	NA	NA	NA	1,45	46	0.978
A375	chr9	C	A	21971177	PASS	CDKN2A	CD2A1_HUMAN	ENSG00000147889	1029	stop_gained	p.E61X	p.E61X	GAG>TAG	exon2:c.181G>T	NM_001195132,NM_000077	benign	tolerated#.#benign#benign#.#.	NA	PS50297#ANK_REP_REGION	NA		NA	NA		NA	133	121913382	5	NA	NA	NA	NA	NA	NA	1,55	56	0.982
A375	chr9	A	G	21974631	PASS	CDKN2A	CD2A1_HUMAN	ENSG00000147889	1029	missense_variant	p.W66R	p.W66R	NA	exon1:c.196T>C	NM_058197	NA	NA	NA	NA	NA		NA	NA		BAY1000394,LEE011,LY2835219,PD_0332991	NA	NA	NA	NA	NA	NA	NA	NA	NA	1,28	30	0.966
A375	chr10	C	T	123247585	PASS	FGFR2	FGFR2_HUMAN	ENSG00000066468	2263	missense_variant	p.E524K,p.E521K,p.E520K,p.E519K,p.E547K,p.E637K,p.E548K,p.E636K	p.E636K	GAA>AAA	exon11:c.1570G>A,exon11:c.1561G>A,exon12:c.1558G>A,exon12:c.1555G>A,exon12:c.1639G>A,exon13:c.1909G>A,exon13:c.1639G>A,exon13:c.1642G>A,exon14:c.1906G>A,exon14:c.1909G>A	NM_023029,NM_000141,NM_022970,NM_001144916,NM_001144917,NM_001144914,NM_001144915,NM_001144913,NM_001144918,NM_001144919	damaging	damaging#possibly_damaging/probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#481#757#1#1	NA	NA		NA	1	NA	FP-1039,ENMD-2076,AZD4547,BGJ398,BRIVANIB,DOVITINIB,E-3810,LENVATINIB,MASITINIB,NINTEDANIB,PONATINIB,REGORAFENIB,TSU-68,VARGATEF,XL228,XL999	NA	NA	NA	NA	77,182289	NA	NA	7,8231	NA	1,181	183	0.995
A375	chr13	G	A	21562627	PASS	LATS2	LATS2_HUMAN	ENSG00000150457	26524	missense_variant	p.T431I	p.T431I	ACC>ATC	exon4:c.1292C>T	NM_014572	mixed	damaging#possibly_damaging#benign#damaging#neutral#tolerated	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	13,38	51	0.745
A375	chr7	C	A	138145436	PASS	TRIM24	TIF1A_HUMAN	ENSG00000122779	8805	missense_variant	p.A48D	p.A48D	GCC>GAC	exon1:c.143C>A	NM_015905,NM_003852	benign	tolerated#benign#benign#damaging#unknown#tolerated	NA	NA	NA	1	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	25,8	33	0.242
A375	chr7	C	T	98509802	PASS	TRRAP	TRRAP_HUMAN	ENSG00000261023	8295	missense_variant	p.S722F	p.S722F	TCC>TTC	exon18:c.2165C>T	NM_001244580,NM_003496	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	NA	NA	NA		NA	NA	NA	NA	134	147405090	3	3,182289	NA	2,8231	2,8231	NA	4,4430	146,225	371	0.606
Femx-1	chr11	A	T	108164164	PASS	ATM	ATM_HUMAN	ENSG00000149311	472	missense_variant	p.Q1579L	p.Q1579L	CAA>CTA	exon31:c.4736A>T	NM_000051	benign	tolerated#benign#benign#damaging#deleterious#tolerated	PB010220#Pfam-B_10220#1575#1713#0#0	NA	NA		NA	NA	1	NA	NA	NA	NA	1,182289	23,182289	NA	NA	NA	NA	0,90	90	1
Femx-1	chr19	A	G	15383907	PASS	BRD4	BRD4_HUMAN	ENSG00000141867	23476	missense_variant	p.S2P	p.S2P	TCT>CCT	exon2:c.4T>C	NM_014299,NM_058243	damaging	damaging#possibly_damaging/probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	90,36	127	0.286
Femx-1	chr22	C	T	29091225	PASS	CHEK2	CHK2_HUMAN	ENSG00000183765	11200	missense_variant	p.S393N,p.S422N,p.S465N,p.S201N	p.S422N	AGT>AAT	exon11:c.1178G>A,exon12:c.1265G>A,exon13:c.1394G>A,exon13:c.602G>A	NM_007194,NM_145862,NM_001257387,NM_001005735	mixed	tolerated#possibly_damaging/probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#220#486#5#4	NA	NA		NA	NA	1	AZD7762	NA	NA	NA	NA	72,182289	NA	NA	NA	NA	92,57	149	0.383
Femx-1	chr10	G	T	123256053	PASS	FGFR2	FGFR2_HUMAN	ENSG00000066468	2263	missense_variant	p.S507Y,p.S504Y,p.S503Y,p.S502Y,p.S530Y,p.S620Y,p.S531Y,p.S619Y	p.S619Y	TCC>TAC	exon10:c.1520C>A,exon10:c.1511C>A,exon11:c.1508C>A,exon11:c.1505C>A,exon11:c.1589C>A,exon12:c.1859C>A,exon12:c.1589C>A,exon12:c.1592C>A,exon13:c.1856C>A,exon13:c.1859C>A	NM_023029,NM_000141,NM_022970,NM_001144916,NM_001144917,NM_001144914,NM_001144915,NM_001144913,NM_001144918,NM_001144919	damaging	damaging#possibly_damaging/probably_damaging#damaging#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#481#757#1#1	NA	NA		NA	1	NA	FP-1039,ENMD-2076,AZD4547,BGJ398,BRIVANIB,DOVITINIB,E-3810,LENVATINIB,MASITINIB,NINTEDANIB,PONATINIB,REGORAFENIB,TSU-68,VARGATEF,XL228,XL999	NA	NA	NA	1,182289	77,182289	NA	NA	7,8231	NA	194,61	255	0.239
Femx-1	chr10	A	T	123256054	PASS	FGFR2	FGFR2_HUMAN	ENSG00000066468	2263	missense_variant	p.S507T,p.S504T,p.S503T,p.S502T,p.S530T,p.S620T,p.S531T,p.S619T	p.S619T	TCC>ACC	exon10:c.1519T>A,exon10:c.1510T>A,exon11:c.1507T>A,exon11:c.1504T>A,exon11:c.1588T>A,exon12:c.1858T>A,exon12:c.1588T>A,exon12:c.1591T>A,exon13:c.1855T>A,exon13:c.1858T>A	NM_023029,NM_000141,NM_022970,NM_001144916,NM_001144917,NM_001144914,NM_001144915,NM_001144913,NM_001144918,NM_001144919	damaging	damaging#benign/possibly_damaging/probably_damaging#damaging#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#481#757#1#1	NA	NA		NA		NA	FP-1039,ENMD-2076,AZD4547,BGJ398,BRIVANIB,DOVITINIB,E-3810,LENVATINIB,MASITINIB,NINTEDANIB,PONATINIB,REGORAFENIB,TSU-68,VARGATEF,XL228,XL999	NA	NA	NA	1,182289	77,182289	NA	NA	7,8231	NA	197,61	258	0.236
Femx-1	chr7	A	T	6431635	PASS	RAC1	RAC1_HUMAN	ENSG00000136238	5879	missense_variant	p.D63V	p.D63V	GAT>GTT	exon3:c.188A>T	NM_006908,NM_018890	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	PF00071.17#Ras#5#178#35#24	PS51420#RHO	NA		NA	NA	NA	NA	NA	NA	NA	NA	50,182289	NA	NA	36,8231	NA	205,44	249	0.177
Femx-5	chr11	A	T	108164164	PASS	ATM	ATM_HUMAN	ENSG00000149311	472	missense_variant	p.Q1579L	p.Q1579L	CAA>CTA	exon31:c.4736A>T	NM_000051	benign	tolerated#benign#benign#damaging#deleterious#tolerated	PB010220#Pfam-B_10220#1575#1713#0#0	NA	NA		NA	NA	1	NA	NA	NA	NA	1,182289	23,182289	NA	NA	NA	NA	0,76	76	1
Femx-5	chr19	A	G	15383907	PASS	BRD4	BRD4_HUMAN	ENSG00000141867	23476	missense_variant	p.S2P	p.S2P	TCT>CCT	exon2:c.4T>C	NM_014299,NM_058243	damaging	damaging#possibly_damaging/probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	88,63	151	0.417
Femx-5	chr22	C	T	29091225	PASS	CHEK2	CHK2_HUMAN	ENSG00000183765	11200	missense_variant	p.S393N,p.S422N,p.S465N,p.S201N	p.S422N	AGT>AAT	exon11:c.1178G>A,exon12:c.1265G>A,exon13:c.1394G>A,exon13:c.602G>A	NM_007194,NM_145862,NM_001257387,NM_001005735	mixed	tolerated#possibly_damaging/probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#220#486#5#4	NA	NA		NA	NA	1	AZD7762	NA	NA	NA	NA	72,182289	NA	NA	NA	NA	57,119	178	0.676
Femx-5	chr15	G	T	91434883	PASS	FES	FES_HUMAN	ENSG00000182511	2242	missense_variant	p.V486F,p.V474F,p.V416F,p.V544F	p.V544F	GTC>TTC	exon10:c.1456G>T,exon10:c.1420G>T,exon10:c.1246G>T,exon12:c.1630G>T	NM_002005,NM_001143783,NM_001143784,NM_001143785	mixed	damaging#benign/possibly_damaging#damaging#damaging#neutral#tolerated	NA	NA	NA	NA	NA	1		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	243,31	274	0.113
Hermes3c	chr5	C	T	1293680	PASS	TERT	TERT_HUMAN	ENSG00000164362	7015	missense_variant	p.E441K	p.E441K	GAG>AAG	exon2:c.1321G>A	NM_001193376,NM_198253	benign	tolerated#benign#benign#benign#neutral#damaging	NA	NA	REGION@376@521@441,REGION@301@538@441,REGION@325@550@441	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	72,43	115	0.374
Hermes4c-pLX3xHA-var4-mCh	chr5	C	T	1293680	PASS	TERT	TERT_HUMAN	ENSG00000164362	7015	missense_variant	p.E441K	p.E441K	GAG>AAG	exon2:c.1321G>A	NM_001193376,NM_198253	benign	tolerated#benign#benign#benign#neutral#damaging	NA	NA	REGION@376@521@441,REGION@301@538@441,REGION@325@550@441		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	81,48	129	0.372
Lox	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA		NA	1	NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	28,67	96	0.705
Lox	chr7	T	C	140507849	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.I208V	p.I208V	ATT>GTT	exon5:c.622A>G	NM_004333	benign	tolerated#benign#benign#damaging#deleterious#tolerated	PF02196.10#RBD#155#227#4#4	PS50898#RBD	NA		NA		NA	NA	NA	NA	NA	NA	4,182289	NA	NA	NA	NA	79,225	304	0.74
Lox	chr5	C	T	149433636	PASS	CSF1R	CSF1R_HUMAN	ENSG00000182578	1436	missense_variant	p.C972Y	p.C972Y	TGC>TAC	exon21:c.2915G>A,exon22:c.2915G>A	NM_005211,NM_001288705	damaging	damaging#probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	NA	NA	NA		NA	IMATINIB,DOVITINIB,DASATINIB,PLX3397,SUNITINIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	64,71	135	0.526
Lox	chr3	A	C	41267302	PASS	CTNNB1	CTNB1_HUMAN	ENSG00000168036	1499	missense_variant	p.I296L	p.I296L	ATT>CTT	exon6:c.886A>C	NM_001098209,NM_001098210,NM_001904	benign	tolerated#benign#benign#damaging#deleterious#tolerated	NA	PS50176#ARM_REPEAT	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	69,109	178	0.612
Lox	chr2	C	A	212652831	PASS	ERBB4	ERBB4_HUMAN	ENSG00000178568	2066	missense_variant	p.D159Y	p.D159Y	GAC>TAC	exon4:c.475G>T	NM_001042599,NM_005235	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF01030.19#Recep_L_domain#55#167#2#1	NA	NA	NA	NA	NA	1	BMS-599626,BMS-690514,DACOMITINIB,PELITINIB	NA	NA	NA	NA	23,182289	NA	NA	4,8231	NA	253,108	361	0.299
Lox	chr6	C	A	149983274	PASS	LATS1	LATS1_HUMAN	ENSG00000131023	9113	missense_variant	p.R995L	p.R995L	CGC>CTC	exon8:c.2984G>T	NM_004690	damaging	.#probably_damaging#damaging#damaging#deleterious#tolerated	PF00069.20#Pkinase#895#1010#2#2	NA	NA	NA	NA	NA		NA	NA	NA	NA	2,182289	9,182289	NA	NA	NA	NA	103,105	208	0.505
Lox	chr2	A	C	112767589	PASS	MERTK	MERTK_HUMAN	ENSG00000153208	10461	missense_variant	p.K675N	p.K675N	AAA>AAC	exon15:c.2025A>C	NM_006343	mixed	damaging#probably_damaging#benign#damaging#unknown#tolerated	PF07714.12#Pkinase_Tyr#587#854#2#1	NA	NA	NA	NA	1	NA	AT9283	NA	NA	NA	NA	19,182289	NA	NA	1,8231	NA	204,44	248	0.177
Lox	chr17	C	T	29560043	PASS	NF1	NF1_HUMAN	ENSG00000196712	4763	stop_gained	p.Q1174X	p.Q1174X	CAG>TAG	exon27:c.3520C>T	NM_001042492,NM_000267	damaging	tolerated#.#.#damaging#deleterious#.	NA	NA	NA	1	NA	NA	1	GDC-0973,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	133,64	199	0.325
Lox	chr1	G	A	156844704	PASS	NTRK1	NTRK1_HUMAN	ENSG00000198400	4914	missense_variant	p.V414M,p.V384M,p.V420M	p.V420M	GTG>ATG	exon10:c.1240G>A,exon11:c.1150G>A,exon11:c.1258G>A	NM_001007792,NM_001012331,NM_002529	benign	tolerated#benign#damaging#damaging#neutral#tolerated	NA	PS00107#PROTEIN_KINASE_ATP	NA		NA	1	NA	NA	NA	NA	1	1,182289	NA	NA	NA	NA	NA	59,111	171	0.653
Lox	chr4	T	C	55138561	PASS	PDGFRA	PGFRA_HUMAN	ENSG00000134853	5156	missense_variant	p.V413A	p.V413A	GTT>GCT	exon9:c.1238T>C	NM_006206	damaging	.#possibly_damaging/probably_damaging#damaging#damaging#unknown#tolerated	NA	NA	NA		NA		NA	IMATINIB,SUNITINIB,DOVITINIB,AMUVATINIB,MEDI-575,RAMUCIRUMAB,CRENOLANIB,MIDOSTAURIN,MOTESANIB,NINTEDANIB,PAZOPANIB,TANDUTINIB,VARGATEF,X-82,PAZOPANI	NA	NA	NA	NA	NA	NA	NA	NA	NA	118,49	167	0.293
Lox	chr5	C	T	149510153	PASS	PDGFRB	PGFRB_HUMAN	ENSG00000113721	5159	missense_variant	p.R439Q	p.R439Q	CGG>CAG	exon9:c.1316G>A	NM_002609	benign	tolerated#benign#benign#benign#neutral#tolerated	NA	NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	29,43	72	0.597
Lox	chr1	C	A	115053598	PASS	TRIM33	TRI33_HUMAN	ENSG00000197323	51592	missense_variant	p.A34S	p.A34S	GCG>TCG	exon1:c.100G>T	NM_015906,NM_033020	benign	tolerated#benign#benign#damaging#unknown#tolerated	NA	NA	REGION@1@147@34		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	0,2	2	1
MeWo	chr1	G	A	179077499	PASS	ABL2	ABL2_HUMAN	ENSG00000143322	27	missense_variant	p.S947F,p.S844F,p.S829F,p.S953F,p.S968F,p.S850F,p.S865F	p.S968F	TCC>TTC	exon11:c.2840C>T,exon12:c.2531C>T,exon12:c.2486C>T,exon12:c.2858C>T,exon12:c.2903C>T,exon13:c.2549C>T,exon13:c.2594C>T	NM_001168239,NM_001168238,NM_001168237,NM_001168236,NM_005158,NM_007314,NM_001136000	benign	tolerated#benign/possibly_damaging/probably_damaging#benign#benign#neutral#tolerated	PB010928#Pfam-B_10928#551#1024#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	35,182289	NA	NA	NA	1,4430	108,69	177	0.39
MeWo	chr9	G	A	136913227	PASS	BRD3	BRD3_HUMAN	ENSG00000169925	8019	missense_variant	p.P355L	p.P355L	CCG>CTG	exon6:c.1064C>T	NM_007371	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	PF00439.20#Bromodomain#315#403#0#0	NA	NA		NA	NA	NA	NA	NA	NA	1	1,182289	8,182289	NA	NA	NA	1,4430	41,15	56	0.268
MeWo	chr9	G	A	136913228	PASS	BRD3	BRD3_HUMAN	ENSG00000169925	8019	missense_variant	p.P355S	p.P355S	CCG>TCG	exon6:c.1063C>T	NM_007371	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	PF00439.20#Bromodomain#315#403#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	1,182289	8,182289	NA	NA	NA	NA	41,15	56	0.268
MeWo	chr19	G	A	15354169	PASS	BRD4	BRD4_HUMAN	ENSG00000141867	23476	missense_variant	p.P904L	p.P904L	CCC>CTC	exon14:c.2711C>T	NM_058243	mixed	damaging#benign#benign#damaging#deleterious#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	91,44	135	0.326
MeWo	chr19	T	A	15366270	PASS	BRD4	BRD4_HUMAN	ENSG00000141867	23476	stop_gained	p.K629X	p.K629X	AAG>TAG	exon10:c.1885A>T	NM_014299,NM_058243	damaging	tolerated#.#.#damaging#deleterious#.	PB015118#Pfam-B_15118#509#647#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	8,182289	NA	NA	NA	NA	79,47	126	0.373
MeWo	chr15	C	T	40494794	PASS	BUB1B	BUB1B_HUMAN	ENSG00000156970	701	missense_variant	p.P545S	p.P545S	CCT>TCT	exon14:c.1633C>T	NM_001211	benign	tolerated#benign#benign#benign#neutral#tolerated	NA	NA	NA		NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	78,126	204	0.618
MeWo	chr17	C	T	37682230	PASS	CDK12	CDK12_HUMAN	ENSG00000167258	51755	missense_variant	p.H1141Y	p.H1141Y	CAC>TAC	exon13:c.3421C>T	NM_016507,NM_015083	benign	damaging#benign#benign#damaging#neutral#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	58,141	199	0.709
MeWo	chr17	C	T	37687561	PASS	CDK12	CDK12_HUMAN	ENSG00000167258	51755	missense_variant	p.P1480S,p.P1489S	p.P1489S	CCT>TCT	exon14:c.4438C>T,exon14:c.4465C>T	NM_016507,NM_015083	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	88,48	136	0.353
MeWo	chr9	G	A	21971120	PASS	CDKN2A	CD2A1_HUMAN	ENSG00000147889	1029	stop_gained	p.R80X	p.R80X	CGA>TGA	exon2:c.238C>T	NM_001195132,NM_000077	benign	tolerated#.#benign#damaging#.#.	NA	PS50297#ANK_REP_REGION	NA		NA	NA	1	NA	133	121913388	68	3,182289	NA	9,8231	NA	NA	23,4430	0,46	46	1
MeWo	chr9	G	A	21971121	PASS	CDKN2A	CD2A2_HUMAN	ENSG00000147889	1029	missense_variant	p.P94S	p.P94S	CCG>TCG	exon2:c.280C>T	NM_058195	mixed	tolerated#benign#.#damaging#neutral#damaging	NA	NA	NA		NA	NA		BAY1000394,LEE011,LY2835219,PD_0332991	NA	NA	1	7,182289	NA	1,8231	4,8231	NA	NA	0,46	46	1
MeWo	chr2	C	T	212483905	PASS	ERBB4	ERBB4_HUMAN	ENSG00000178568	2066	missense_variant	p.M766I	p.M766I	ATG>ATA	exon19:c.2298G>A	NM_001042599,NM_005235	damaging	damaging#benign#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#718#974#14#8	NA	NA	NA	NA	NA		BMS-599626,BMS-690514,DACOMITINIB,PELITINIB	NA	NA	NA	NA	57,182289	NA	NA	5,8231	NA	161,123	284	0.433
MeWo	chr2	G	A	212566835	PASS	ERBB4	ERBB4_HUMAN	ENSG00000178568	2066	missense_variant	p.S449F	p.S449F	TCC>TTC	exon12:c.1346C>T	NM_001042599,NM_005235	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	PF01030.19#Recep_L_domain#358#478#2#1	NA	NA	NA	NA	NA		BMS-599626,BMS-690514,DACOMITINIB,PELITINIB	NA	NA	NA	NA	19,182289	NA	NA	3,8231	NA	62,49	111	0.441
MeWo	chr8	G	A	38282209	PASS	FGFR1	FGFR1_HUMAN	ENSG00000077782	2260	missense_variant	p.P163S,p.P161S,p.P252S,p.P250S,p.P244S,p.P283S	p.P252S	CCT>TCT	exon6:c.487C>T,exon6:c.481C>T,exon7:c.754C>T,exon7:c.748C>T,exon8:c.730C>T,exon8:c.847C>T	NM_001174065,NM_001174064,NM_015850,NM_001174066,NM_001174063,NM_023110,NM_023105,NM_001174067,NM_023106	damaging	tolerated#possibly_damaging/probably_damaging#damaging#damaging#deleterious#damaging	NA	NA	NA	1	NA	NA	NA	FP-1039,ENMD-2076,AZD4547,BGJ398,DOVITINIB,E-3810,MASITINIB,NINTEDANIB,ORANTINIB,PONATINIB,VARGATEF,XL228	NA	NA	NA	1,182289	NA	NA	NA	NA	NA	140,39	179	0.218
MeWo	chr10	C	T	123310941	PASS	FGFR2	FGFR2_HUMAN	ENSG00000066468	2263	missense_variant	p.E48K,p.E74K,p.E163K	p.E163K	GAA>AAA	exon2:c.142G>A,exon3:c.142G>A,exon3:c.220G>A,exon4:c.487G>A,exon4:c.220G>A,exon5:c.487G>A	NM_023029,NM_000141,NM_022970,NM_001144916,NM_001144917,NM_001144914,NM_001144915,NM_001144913,NM_001144918,NM_001144919	mixed	damaging#benign/possibly_damaging#benign#damaging#deleterious#tolerated	PF07679.11#I-set#162#248#0#0	NA	REGION@161@178@163		NA	1	NA	FP-1039,ENMD-2076,AZD4547,BGJ398,BRIVANIB,DOVITINIB,E-3810,LENVATINIB,MASITINIB,NINTEDANIB,PONATINIB,REGORAFENIB,TSU-68,VARGATEF,XL228,XL999	NA	NA	NA	NA	15,182289	NA	NA	4,8231	2,4430	60,118	178	0.663
MeWo	chr6	A	T	116288768	PASS	FRK	FRK_HUMAN	ENSG00000111816	2444	missense_variant	p.W249R	p.W249R	TGG>AGG	exon4:c.745T>A	NM_002031	damaging	damaging#probably_damaging#benign#damaging#deleterious#tolerated	PF07714.12#Pkinase_Tyr#234#487#0#0	PS00107#PROTEIN_KINASE_ATP	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	25,182289	NA	NA	NA	NA	151,126	277	0.455
MeWo	chr4	G	A	55948129	PASS	KDR	VGFR2_HUMAN	ENSG00000128052	3791	missense_variant	p.S1281F	p.S1281F	TCT>TTT	exon29:c.3842C>T	NM_002253	benign	tolerated#benign#benign#damaging#neutral#tolerated	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	1	1,182289	NA	1,8231	1,8231	NA	NA	13,41	54	0.759
MeWo	chr6	G	A	150005453	PASS	LATS1	LATS1_HUMAN	ENSG00000131023	9113	missense_variant	p.P258S	p.P258S	CCA>TCA	exon4:c.772C>T	NM_001270519,NM_004690	mixed	.#benign/probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	107,91	198	0.46
MeWo	chr7	C	T	116340234	PASS	MET	MET_HUMAN	ENSG00000105976	4233	missense_variant	p.P366S	p.P366S	CCT>TCT	exon2:c.1096C>T	NM_000245,NM_001127500	mixed	tolerated#benign/possibly_damaging#benign#damaging#deleterious#tolerated	PF01403.14#Sema#52#500#4#2	NA	NA	1	NA	1	NA	CABOZANTANIB,AMG208,AMG_208,AMUVATINIB,LY2875358,ONARTUZUMAB,ARQ_197,ARQ197,BMS-777607,BMS777607,CABOZANTINIB,COMETRIQ,CRIZOTINIB,EMD1214063,FORETINIB,GSK1363089,INC280,INCB028060,INCB28060,JNJ38877605,METMAB,MGCD265,MK-2461,MK2461,PF-04217903,PF-4217903,SGX523,TIVANTINIB	NA	NA	NA	NA	54,182289	NA	NA	NA	NA	166,171	337	0.507
MeWo	chr3	C	T	37067242	PASS	MLH1	MLH1_HUMAN	ENSG00000076242	4292	missense_variant	p.R144C,p.R385C,p.R287C	p.R385C	CGT>TGT	exon11:c.430C>T,exon12:c.1153C>T,exon12:c.859C>T,exon12:c.430C>T,exon13:c.430C>T	NM_001258274,NM_001258273,NM_001258271,NM_001167617,NM_000249,NM_001167618,NM_001167619	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	NA	NA	NA		NA	NA	1	NA	136	63750760	1	2,182289	NA	NA	NA	NA	NA	41,21	62	0.339
MeWo	chr17	C	T	29576033	PASS	NF1	NF1_HUMAN	ENSG00000196712	4763	stop_gained	p.Q1336X	p.Q1336X	CAG>TAG	exon30:c.4006C>T	NM_001042492,NM_000267	damaging	tolerated#.#.#damaging#deleterious#.	PF00616.14#RasGAP#1256#1451#0#0	PS50018#RAS_GTPASE_ACTIV_2	NA		NA	NA		GDC-0973,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	NA	NA	NA	NA	38,182289	NA	NA	1,8231	NA	0,95	95	1
MeWo	chr4	A	C	55161424	PASS	PDGFRA	PGFRA_HUMAN	ENSG00000134853	5156	missense_variant	p.E1085D	p.E1085D	GAA>GAC	exon23:c.3255A>C	NM_006206	mixed	damaging#probably_damaging#benign#damaging#unknown#tolerated	NA	NA	NA		NA	1	NA	IMATINIB,SUNITINIB,DOVITINIB,AMUVATINIB,MEDI-575,RAMUCIRUMAB,CRENOLANIB,MIDOSTAURIN,MOTESANIB,NINTEDANIB,PAZOPANIB,TANDUTINIB,VARGATEF,X-82,PAZOPANI	NA	NA	NA	1,182289	NA	NA	NA	NA	NA	78,37	115	0.322
MeWo	chr5	G	A	149497316	PASS	PDGFRB	PGFRB_HUMAN	ENSG00000113721	5159	missense_variant	p.P1001L	p.P1001L	CCC>CTC	exon22:c.3002C>T	NM_002609	benign	damaging#benign#benign#damaging#neutral#tolerated	NA	NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	9,15	24	0.625
MeWo	chr5	G	A	149497317	PASS	PDGFRB	PGFRB_HUMAN	ENSG00000113721	5159	missense_variant	p.P1001S	p.P1001S	CCC>TCC	exon22:c.3001C>T	NM_002609	benign	tolerated#benign#benign#benign#neutral#tolerated	NA	NA	NA		NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	16,9	25	0.36
MeWo	chr17	G	A	64783003	PASS	PRKCA	KPCA_HUMAN	ENSG00000154229	5578	missense_variant	p.D542N	p.D542N	GAT>AAT	exon15:c.1624G>A	NM_002737	mixed	tolerated#possibly_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#339#597#13#8	NA	NA	NA	NA		NA	AFFINITAC,ENZASTAURIN,MIDOSTAURIN,SOPHORETIN	NA	NA	NA	NA	12,182289	NA	NA	NA	NA	257,112	369	0.304
MeWo	chr6	G	A	117650502	PASS	ROS1	ROS1_HUMAN	ENSG00000047936	6098	missense_variant	p.L1786F	p.L1786F	CTT>TTT	exon32:c.5356C>T	NM_002944	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	NA	NA	NA	1	NA		NA	ASP3026,CRIZOTINIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	125,119	244	0.488
MeWo	chr6	C	T	117710518	PASS	ROS1	ROS1_HUMAN	ENSG00000047936	6098	missense_variant	p.G585E	p.G585E	GGA>GAA	exon12:c.1754G>A	NM_002944	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	NA	NA	NA		NA		NA	ASP3026,CRIZOTINIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	78,96	174	0.552
MeWo	chr21	G	A	44840971	PASS	SIK1	SIK1_HUMAN	ENSG00000142178	150094	missense_variant	p.P223S	p.P223S	CCC>TCC	exon7:c.667C>T	NM_173354	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	PF00069.20#Pkinase#27#278#0#0	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	13,182289	NA	NA	3,8231	NA	0,130	130	1
MeWo	chr20	G	A	36031732	PASS	SRC	SRC_HUMAN	ENSG00000197122	6714	missense_variant	p.D521N	p.D521N	GAC>AAC	exon14:c.1561G>A	NM_198291,NM_005417	damaging	damaging#possibly_damaging#benign#damaging#deleterious#tolerated	NA	NA	NA	NA	NA	1	NA	BOSUTINIB,DASATINIB,KX2-391,SARACATINIB,XL228,XL999	NA	NA	NA	NA	NA	NA	NA	NA	NA	68,391	459	0.852
MeWo	chr9	G	A	93636513	PASS	SYK	KSYK_HUMAN	ENSG00000165025	6850	missense_variant	p.E292K,p.E315K	p.E315K	GAG>AAG	exon7:c.874G>A,exon8:c.943G>A	NM_001174168,NM_001135052,NM_003177,NM_001174167	benign	tolerated#benign#benign#benign#neutral#tolerated	NA	NA	REGION@260@370@315	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1,102	103	0.99
MeWo	chr17	G	A	7576897	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	stop_gained	p.Q185X,p.Q158X,p.Q278X,p.Q317X	p.Q317X	CAG>TAG	exon5:c.553C>T,exon5:c.472C>T,exon8:c.832C>T,exon9:c.949C>T,exon9:c.832C>T	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	benign	tolerated#.#.#damaging#neutral#.	NA	NA	REGION@300@393@317,REGION@100@370@317,MOTIF@305@321@317		NA	NA	1	NA	NA	NA	23	8,182289	NA	1,8231	NA	NA	6,4430	69,34	103	0.33
MeWo	chr17	C	T	7577509	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	missense_variant	p.E126K,p.E99K,p.E219K,p.E258K	p.E258K	GAA>AAA	exon3:c.376G>A,exon3:c.295G>A,exon6:c.655G>A,exon7:c.772G>A,exon7:c.655G>A	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00870.13#P53#95#289#11#9	NA	REGION@116@292@258,REGION@100@300@258,REGION@100@370@258,REGION@256@294@258,DNA_BIND@102@292@258		NA	NA		AD.P53-DC,EP-2101,MUTANT_P53_PEPTIDE_PULSED_DENDRITIC_CELL	133	121912652	41	85,182289	11903,182289	NA	NA	40,8231	NA	29,61	90	0.678
Mm1	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA		NA	1	NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	59,55	114	0.482
Mm1	chr17	T	G	41244216	PASS	BRCA1	BRCA1_HUMAN	ENSG00000012048	672	missense_variant	p.Q1111P,p.Q1064P	p.Q1111P	CAA>CCA	exon10:c.3332A>C,exon9:c.3191A>C	NM_007297,NM_007300,NM_007294	benign	damaging#benign#damaging#benign#neutral#tolerated	NA	NA	NA		NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	139,121	260	0.465
Mm1	chr19	G	A	15355564	PASS	BRD4	BRD4_HUMAN	ENSG00000141867	23476	missense_variant	p.P723L	p.P723L	CCG>CTG	exon12:c.2168C>T	NM_058243	benign	damaging#benign#benign#damaging#neutral#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	55,55	110	0.5
Mm1	chr1	C	T	23236915	PASS	EPHB2	EPHB2_HUMAN	ENSG00000133216	2048	missense_variant	p.P849L,p.P848L	p.P849L,p.P848L	CCC>CTC	exon14:c.2546C>T,exon14:c.2543C>T	NM_017449,NM_004442	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	50,46	96	0.479
Mm1	chr13	G	A	28623604	PASS	FLT3	FLT3_HUMAN	ENSG00000122025	2322	missense_variant	p.S318L	p.S318L	TCA>TTA	exon8:c.953C>T	NM_004119	benign	tolerated#benign/possibly_damaging#benign#damaging#neutral#tolerated	PF00047.20#ig#265#332#1#1	NA	NA	1	NA	1	NA	NA	NA	NA	NA	NA	7,182289	NA	NA	NA	NA	114,124	238	0.521
Mm1	chr10	G	A	89690805	PASS	PTEN	PTEN_HUMAN	ENSG00000171862	5728	missense_variant	p.C71Y	p.C71Y	TGT>TAT	exon4:c.212G>A	NM_000314	damaging	.#probably_damaging#damaging#damaging#deleterious#damaging	PF00782.15#DSPc#45#171#0#0	NA	NA		NA	NA	1	BAY80-6946,BYL719,CETUXIMAB,DS-7423,ERLOTINIB,EVEROLIMUS,GEFITINIB,GSK2126458,NVP-BEZ235,PANITUMUMAB,PF-04691502,PF-05212384,TEMSIROLIMUS,VANDETANIB,XL-147,XL765,ZSTK474	NA	NA	3	3,182289	697,182289	NA	NA	9,8231	2,4430	0,71	71	1
Mm5	chr20	A	G	54948582	PASS	AURKA	AURKA_HUMAN	ENSG00000087586	6790	missense_variant	p.Y246H	p.Y246H	TAC>CAC	exon7:c.736T>C,exon8:c.736T>C,exon9:c.736T>C	NM_003600,NM_198433,NM_198434,NM_198435,NM_198436,NM_198437	damaging	damaging#possibly_damaging/probably_damaging#damaging#damaging#deleterious#tolerated	PF00069.20#Pkinase#133#383#2#2	NA	NA	NA	NA	1	NA	ALISERTIB_SODIUM,ALISERTIB,AMG900,AS703569,AT9283,BI847325,CYC116,DANUSERTIB,ENMD-0276,ENMD-2076,MK5108,MLN8237,MLN_8237,PF-03814735,SN-314,SNS-314,TAK901,TOZASERTIB,XL228	NA	NA	1	1,182289	15,182289	NA	NA	2,8231	NA	122,46	168	0.274
Mm5	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA	1	NA		NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	43,102	145	0.703
Mm5	chr9	G	A	136901264	PASS	BRD3	BRD3_HUMAN	ENSG00000169925	8019	missense_variant	p.S609F	p.S609F	TCC>TTC	exon10:c.1826C>T	NM_007371	damaging	damaging#benign#damaging#damaging#deleterious#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	155,97	252	0.385
Mm5	chr9	A	G	21974675	PASS	CDKN2A	CD2A1_HUMAN	ENSG00000147889	1029	missense_variant	p.V51A	p.V51A	NA	exon1:c.152T>C	NM_058197	NA	NA	NA	NA	NA		NA	NA	1	BAY1000394,LEE011,LY2835219,PD_0332991	NA	NA	3	NA	NA	NA	NA	NA	NA	23,65	88	0.739
Mm5	chr17	G	A	48273698	PASS	COL1A1	CO1A1_HUMAN	ENSG00000108821	1277	missense_variant	p.R312C	p.R312C	CGC>TGC	exon14:c.934C>T	NM_000088	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF01391.13#Collagen#296#355#0#0	NA	REGION@179@1192@312		NA	NA	NA	NA	130	72645347	1	1,182289	4,182289	NA	NA	NA	NA	0,265	266	1
Mm5	chr11	A	T	11373666	PASS	CSNK2A3	CSK23_HUMAN	ENSG00000254598	283106	missense_variant	p.M334K	p.M334K	NA	exon1:c.1001T>A	NM_001256686	NA	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	82,33	115	0.287
Mm5	chr2	T	A	212578306	PASS	ERBB4	ERBB4_HUMAN	ENSG00000178568	2066	missense_variant	p.E317D	p.E317D	GAA>GAT	exon8:c.951A>T	NM_001042599,NM_005235	mixed	damaging#benign#benign#damaging#deleterious#tolerated	PF00757.15#Furin-like#176#335#2#1	NA	NA	NA	NA	NA	1	BMS-599626,BMS-690514,DACOMITINIB,PELITINIB	NA	NA	NA	1,182289	40,182289	NA	1,8231	1,8231	NA	86,107	193	0.554
Mm5	chr13	G	A	28611420	PASS	FLT3	FLT3_HUMAN	ENSG00000122025	2322	missense_variant	p.S404F	p.S404F	TCC>TTC	exon10:c.1211C>T	NM_004119	mixed	tolerated#possibly_damaging/probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	NA	1	NA	1	NA	AMUVATINIB,SORAFENIB,AS703569,CABOZANTINIB,ENMD-0276,LESTAURTINIB,MIDOSTAURIN,PLX108-01,PLX3397,PONATINIB,QUIZARTINIB,TANDUTINIB,XL999,SUNITINIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	61,44	105	0.419
Mm5	chr6	C	T	116288883	PASS	FRK	FRK_HUMAN	ENSG00000111816	2444	splice_acceptor_variant	NA	NA	NA	exon5:c.631-1G>A	NM_002031	damaging	.#.#.#damaging#.#.	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	33,44	77	0.571
Mm5	chr5	T	G	1255487	PASS	TERT	TERT_HUMAN	ENSG00000164362	7015	missense_variant	p.Q961H,p.Q1024H	p.Q1024H	CAA>CAC	exon13:c.2883A>C,exon14:c.3072A>C	NM_001193376,NM_198253	benign	tolerated#benign#benign#benign#neutral#damaging	NA	NA	REGION@936@1132@1024	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	76,33	109	0.303
Mm5	chr17	C	T	7577141	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	missense_variant	p.G134E,p.G107E,p.G227E,p.G266E	p.G266E	GGA>GAA	exon4:c.401G>A,exon4:c.320G>A,exon7:c.680G>A,exon8:c.797G>A,exon8:c.680G>A	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00870.13#P53#95#289#11#9	NA	REGION@100@300@266,REGION@116@292@266,DNA_BIND@102@292@266,REGION@256@294@266,REGION@100@370@266		NA	NA	1	AD.P53-DC,EP-2101,MUTANT_P53_PEPTIDE_PULSED_DENDRITIC_CELL	136	193920774	50	147,182289	11903,182289	1,8231	1,8231	40,8231	5,4430	33,63	96	0.656
Wm115	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA		NA	1	NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	38,46	84	0.548
Wm115	chr4	C	T	1806186	PASS	FGFR3	FGFR3_HUMAN	ENSG00000068078	2261	missense_variant	p.P402L,p.P404L	p.P402L	CCC>CTC	exon9:c.1205C>T,exon9:c.1211C>T	NM_000142,NM_001163213	benign	tolerated#benign#benign#damaging#neutral#damaging	PB004875#Pfam-B_4875#371#459#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	478,182289	NA	NA	NA	NA	66,126	192	0.656
Wm115	chr3	G	T	37061826	PASS	MLH1	MLH1_HUMAN	ENSG00000076242	4292	missense_variant	p.D63Y,p.D304Y,p.D206Y	p.D304Y	GAT>TAT	exon10:c.187G>T,exon11:c.910G>T,exon11:c.616G>T,exon11:c.187G>T,exon12:c.187G>T	NM_001258274,NM_001258273,NM_001258271,NM_001167617,NM_000249,NM_001167618,NM_001167619	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF01119.14#DNA_mis_repair#216#335#3#3	NA	NA		NA	NA	1	NA	NA	NA	NA	NA	18,182289	NA	NA	1,8231	NA	186,53	239	0.222
Wm115	chr3	C	T	170009667	PASS	PRKCI	KPCI_HUMAN	ENSG00000163558	5584	missense_variant	p.T410I	p.T410I	ACC>ATC	exon13:c.1229C>T	NM_002740	mixed	.#probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#254#522#4#2	NA	NA	NA	NA	1		SOPHORETIN	NA	NA	NA	NA	31,182289	NA	NA	NA	NA	45,10	55	0.182
Wm1341	chr7	A	C	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600G	p.V600G	GTG>GGG	exon15:c.1799T>G	NM_004333	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA	1	NA		NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	NA	NA	11	18463,182289	18905,182289	1,8231	3762,8231	3868,8231	NA	40,136	176	0.773
Wm1341	chr7	C	T	140453137	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600M	p.V600M	GTG>ATG	exon15:c.1798G>A	NM_004333	damaging	damaging#possibly_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA		NA		NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	133	121913378	23	18463,182289	18905,182289	6,8231	3762,8231	3868,8231	NA	39,136	175	0.777
Wm1341	chr17	G	A	37673788	PASS	CDK12	CDK12_HUMAN	ENSG00000167258	51755	missense_variant	p.R981H	p.R981H	CGT>CAT	exon10:c.2942G>A	NM_016507,NM_015083	damaging	damaging#probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#727#1020#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	1,182289	34,182289	NA	NA	NA	1,4430	283,71	354	0.201
Wm1341	chr5	G	A	108233533	PASS	FER	FER_HUMAN	ENSG00000151422	2241	missense_variant	p.R407Q	p.R407Q	CGA>CAA	exon10:c.1220G>A	NM_005246	mixed	tolerated#probably_damaging#benign#damaging#deleterious#tolerated	NA	PS00107#PROTEIN_KINASE_ATP	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	111,27	138	0.196
Wm1341	chr1	C	G	27950380	PASS	FGR	FGR_HUMAN	ENSG00000000938	2268	missense_variant	p.K16N	p.K16N	AAG>AAC	exon3:c.48G>C	NM_001042747,NM_001042729,NM_005248	benign	tolerated#possibly_damaging#benign#benign#neutral#tolerated	NA	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	34,45	79	0.57
Wm1341	chr15	G	A	66729174	PASS	MAP2K1	MP2K1_HUMAN	ENSG00000169032	5604	missense_variant	p.G128S	p.G128S	GGC>AGC	exon3:c.382G>A	NM_002755	damaging	tolerated#possibly_damaging/probably_damaging#benign#damaging#deleterious#damaging	PF00069.20#Pkinase#68#361#12#9	NA	NA	1	NA	NA	NA	AS-703026,AZD6244,AZD8330,BAY86-9766,BI847325,CI-1040,GDC-0623,GDC-0973,GSK1120212,MEK162,MEKINIST,MSC1936369B,PD0325901,PD325901,PIMASERTIB,RDEA119,REFAMETINIB,RO4987655,SELUMETINIB,SORAFENIB,TAK-733,TRAMETINIB	NA	NA	NA	2,182289	51,182289	NA	NA	21,8231	NA	67,50	117	0.427
Wm1366	chr9	G	A	21974684	PASS	CDKN2A	CD2A1_HUMAN	ENSG00000147889	1029	missense_variant	p.P48L	p.P48L	CCG>CTG	exon1:c.143C>T	NM_001195132,NM_000077,NM_058197	damaging	damaging#possibly_damaging/probably_damaging#benign#damaging#.#damaging	NA	PS50297#ANK_REP_REGION	NA		NA	NA	1	BAY1000394,LEE011,LY2835219,PD_0332991	NA	NA	6	9,182289	NA	3,8231	5,8231	NA	3,4430	0,40	40	1
Wm1366	chr17	G	A	48267932	PASS	COL1A1	CO1A1_HUMAN	ENSG00000108821	1277	missense_variant	p.A790V	p.A790V	GCT>GTT	exon34:c.2369C>T	NM_000088	benign	tolerated#benign#benign#damaging#neutral#damaging	PF01391.13#Collagen#779#838#0#0	NA	REGION@179@1192@790		NA	NA	NA	NA	NA	NA	NA	NA	3,182289	NA	NA	NA	NA	37,47	84	0.56
Wm1366	chr1	C	T	23107964	PASS	EPHB2	EPHB2_HUMAN	ENSG00000133216	2048	missense_variant	p.H38Y	p.H38Y	CAT>TAT	exon2:c.112C>T	NM_017449,NM_004442	benign	tolerated#benign#benign#damaging#deleterious#tolerated	NA	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	1,167	168	0.994
Wm1366	chr10	A	T	123256153	PASS	FGFR2	FGFR2_HUMAN	ENSG00000066468	2263	missense_variant	p.Y474N,p.Y471N,p.Y470N,p.Y469N,p.Y497N,p.Y587N,p.Y498N,p.Y586N	p.Y586N	TAC>AAC	exon10:c.1420T>A,exon10:c.1411T>A,exon11:c.1408T>A,exon11:c.1405T>A,exon11:c.1489T>A,exon12:c.1759T>A,exon12:c.1489T>A,exon12:c.1492T>A,exon13:c.1756T>A,exon13:c.1759T>A	NM_023029,NM_000141,NM_022970,NM_001144916,NM_001144917,NM_001144914,NM_001144915,NM_001144913,NM_001144918,NM_001144919	mixed	tolerated#benign/possibly_damaging/probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#481#757#1#1	NA	MOD_RES@586@586@586	1	NA	1	NA	FP-1039,ENMD-2076,AZD4547,BGJ398,BRIVANIB,DOVITINIB,E-3810,LENVATINIB,MASITINIB,NINTEDANIB,PONATINIB,REGORAFENIB,TSU-68,VARGATEF,XL228,XL999	NA	NA	NA	NA	77,182289	NA	NA	7,8231	NA	123,123	246	0.5
Wm1366	chr1	C	T	27941404	PASS	FGR	FGR_HUMAN	ENSG00000000938	2268	missense_variant	p.G351D	p.G351D	GGC>GAC	exon10:c.1052G>A	NM_001042747,NM_001042729,NM_005248	mixed	damaging#probably_damaging#benign#damaging#neutral#tolerated	PF07714.12#Pkinase_Tyr#263#512#12#5	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	13,182289	NA	NA	1,8231	NA	1,133	134	0.993
Wm1366	chr4	C	T	55971104	PASS	KDR	VGFR2_HUMAN	ENSG00000128052	3791	missense_variant	p.E565K	p.E565K	GAG>AAG	exon13:c.1693G>A	NM_002253	damaging	damaging#benign/possibly_damaging#damaging#damaging#deleterious#tolerated	PF13895.1#Ig_2#550#661#0#0	NA	NA	1	NA	NA	NA	AEE788,AEE_788,SORAFENIB,RAMUCIRUMAB,APATINIB,AXITINIB,BMS-690514,BRIVANIB,CABOZANTINIB,CEDIRANIB,CT-322,DOVITINIB,E-3810,ENMD-0276,ENMD-2076,FORETINIB,LENVATINIB,LINIFANIB,MGCD265,MIDOSTAURIN,MOTESANIB,NEOVASTAT,NINTEDANIB,ORANTINIB,PAZOPANIB,PONATINIB,RAF265,REGORAFENIB,TELATINIB,TIVOZANIB,TSU-68,VANDETANIB,VARGATEF,VATALANIB,X-82,XL647,XL820,XL999,SUNITINIB,VADIMEZAN	NA	NA	NA	NA	13,182289	NA	NA	NA	NA	138,127	265	0.479
Wm1366	chr13	G	A	21563270	PASS	LATS2	LATS2_HUMAN	ENSG00000150457	26524	missense_variant	p.P217S	p.P217S	CCC>TCC	exon4:c.649C>T	NM_014572	benign	tolerated#benign#benign#benign#neutral#tolerated	PB015214#Pfam-B_15214#1#239#0#0	NA	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	18,182289	NA	NA	NA	NA	45,57	102	0.559
Wm1366	chr2	C	T	112766008	PASS	MERTK	MERTK_HUMAN	ENSG00000153208	10461	missense_variant	p.A639V	p.A639V	GCG>GTG	exon14:c.1916C>T	NM_006343	mixed	tolerated#probably_damaging#benign#damaging#unknown#damaging	PF07714.12#Pkinase_Tyr#587#854#2#1	NA	NA	NA	NA	1	NA	AT9283	NA	NA	NA	NA	19,182289	NA	NA	1,8231	NA	110,84	194	0.433
Wm1366	chr17	C	T	29665063	PASS	NF1	NF1_HUMAN	ENSG00000196712	4763	missense_variant	p.P2221L,p.P2242L	p.P2242L	CCA>CTA	exon44:c.6662C>T,exon45:c.6725C>T	NM_001042492,NM_000267	damaging	damaging#probably_damaging#damaging#damaging#deleterious#tolerated	NA	NA	NA	1	NA	NA	1	GDC-0973,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	138,113	251	0.45
Wm1366	chr1	T	A	115256529	PASS	NRAS	RASN_HUMAN	ENSG00000213281	4893	missense_variant	p.Q61L	p.Q61L	CAA>CTA	exon3:c.182A>T	NM_002524	damaging	damaging#possibly_damaging#damaging#damaging#unknown#damaging	PF00071.17#Ras#5#165#7#5	PS51421#RAS	NP_BIND@57@61@61		NA	1	NA	NA	120	11554290	196	1718,182289	2839,182289	87,8231	855,8231	1025,8231	15,4430	114,167	282	0.594
Wm1366	chr15	C	T	88420180	PASS	NTRK3	NTRK3_HUMAN	ENSG00000140538	4916	missense_variant	p.D814N,p.D822N,p.D836N	p.D836N	GAC>AAC	exon18:c.2440G>A,exon19:c.2464G>A,exon20:c.2506G>A	NM_002530,NM_001012338,NM_001243101	damaging	damaging#possibly_damaging/probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	107,85	192	0.443
Wm1366	chr15	G	A	88678334	PASS	NTRK3	NTRK3_HUMAN	ENSG00000140538	4916	missense_variant	p.P401L	p.P401L	CCA>CTA	exon10:c.1202C>T	NM_002530,NM_001007156,NM_001243101,NM_001012338	benign	tolerated#benign#benign#damaging#neutral#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	1,182289	NA	NA	1,8231	NA	NA	64,58	122	0.475
Wm1366	chr16	C	G	23634354	PASS	PALB2	PALB2_HUMAN	ENSG00000083093	79728	missense_variant	p.V978L	p.V978L	GTT>CTT	exon9:c.2932G>C	NM_024675	mixed	damaging#benign#damaging#benign#deleterious#tolerated	NA	NA	REGION@853@1186@978		NA	NA	1	NA	NA	NA	NA	1,182289	NA	NA	NA	NA	NA	289,9	298	0.03
Wm1366	chr7	G	A	6431598	PASS	RAC1	RAC1_HUMAN	ENSG00000136238	5879	missense_variant	p.V51M	p.V51M	GTG>ATG	exon3:c.151G>A	NM_006908,NM_018890	damaging	damaging#benign/possibly_damaging#damaging#damaging#deleterious#tolerated	PF00071.17#Ras#5#178#35#24	PS51420#RHO	NA		NA	NA	NA	NA	NA	NA	NA	NA	50,182289	NA	NA	36,8231	NA	89,190	279	0.681
Wm1366	chr6	T	C	166944755	PASS	RPS6KA2	KS6A2_HUMAN	ENSG00000071242	6196	missense_variant	p.Y88C,p.Y96C	p.Y88C	TAC>TGC	exon3:c.263A>G,exon4:c.287A>G	NM_021135,NM_001006932	damaging	damaging#probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#59#318#3#2	PS00107#PROTEIN_KINASE_ATP	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	19,182289	NA	NA	1,8231	NA	15,9	24	0.375
Wm1366	chr17	C	T	7577085	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	missense_variant	p.E153K,p.E126K,p.E246K,p.E285K	p.E285K	GAG>AAG	exon4:c.457G>A,exon4:c.376G>A,exon7:c.736G>A,exon8:c.853G>A,exon8:c.736G>A	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00870.13#P53#95#289#11#9	NA	DNA_BIND@102@292@285,REGION@100@370@285,REGION@100@300@285,REGION@116@292@285,REGION@256@294@285	1	NA	NA		AD.P53-DC,EP-2101,MUTANT_P53_PEPTIDE_PULSED_DENDRITIC_CELL	132	112431538	101	127,182289	11903,182289	NA	NA	40,8231	7,4430	0,116	116	1
Wm1382	chr7	G	A	55238195	PASS	EGFR	EGFR_HUMAN	ENSG00000146648	1956	stop_gained	p.W692X	p.W692X	TGG>TGA	exon16:c.2076G>A	NM_201284	benign	tolerated#.#.#benign#.#.	NA	NA	NA		NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	91,6	97	0.062
Wm1382	chr4	T	A	55599340	PASS	KIT	KIT_HUMAN	ENSG00000157404	3815	missense_variant	p.N822K,p.N818K	p.N822K	AAT>AAA	exon17:c.2466T>A,exon17:c.2454T>A	NM_000222,NM_001093772	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#589#924#23#13	NA	NA		NA	1	NA	DOVITINIB,AMUVATINIB,NILOTINIB,SORAFENIB,SUNITINIB,AS703569,AXITINIB,CABOZANTINIB,CEDIRANIB,DASATINIB,MASITINIB,MIDOSTAURIN,MOTESANIB,IMATINIB,PAZOPANIB,PLX108-01,PLX3397,REGORAFENIB,TANDUTINIB,TELATINIB,VATALANIB,XL820	133	121913514	7	28,182289	1174,182289	3,8231	7,8231	50,8231	NA	461,318	783	0.408
Wm1382	chr5	C	G	1294171	PASS	TERT	TERT_HUMAN	ENSG00000164362	7015	missense_variant	p.R277T	p.R277T	AGA>ACA	exon2:c.830G>C	NM_001193376,NM_198253	benign	tolerated#benign#benign#benign#neutral#damaging	NA	NA	REGION@231@324@277		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	181,29	210	0.138
Wm1382	chr1	A	G	114948266	PASS	TRIM33	TRI33_HUMAN	ENSG00000197323	51592	missense_variant	p.M845T	p.M845T	ATG>ACG	exon15:c.2534T>C	NM_015906,NM_033020	benign	tolerated#benign#benign#benign#neutral#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	2,137	139	0.986
Wm239	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA		NA	1	NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	66,99	165	0.6
Wm239	chr19	T	C	15349915	PASS	BRD4	BRD4_HUMAN	ENSG00000141867	23476	missense_variant	p.E1246G	p.E1246G	GAG>GGG	exon18:c.3737A>G	NM_058243	damaging	damaging#probably_damaging#benign#damaging#deleterious#tolerated	PB014896#Pfam-B_14896#1187#1263#0#0	NA	REGION@1047@1362@1246		NA	NA	NA	NA	NA	NA	NA	NA	9,182289	NA	NA	NA	NA	68,11	79	0.139
Wm239	chr4	C	T	1806186	PASS	FGFR3	FGFR3_HUMAN	ENSG00000068078	2261	missense_variant	p.P402L,p.P404L	p.P402L	CCC>CTC	exon9:c.1205C>T,exon9:c.1211C>T	NM_000142,NM_001163213	benign	tolerated#benign#benign#damaging#neutral#damaging	PB004875#Pfam-B_4875#371#459#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	478,182289	NA	NA	NA	NA	134,82	216	0.38
Wm239	chr3	C	T	170009667	PASS	PRKCI	KPCI_HUMAN	ENSG00000163558	5584	missense_variant	p.T410I	p.T410I	ACC>ATC	exon13:c.1229C>T	NM_002740	mixed	.#probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#254#522#4#2	NA	NA	NA	NA	1	1	SOPHORETIN	NA	NA	NA	NA	31,182289	NA	NA	NA	NA	223,173	396	0.437
Wm266-4	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA	1	NA		NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	54,125	179	0.698
Wm266-4	chr4	C	T	1806186	PASS	FGFR3	FGFR3_HUMAN	ENSG00000068078	2261	missense_variant	p.P402L,p.P404L	p.P402L	CCC>CTC	exon9:c.1205C>T,exon9:c.1211C>T	NM_000142,NM_001163213	benign	tolerated#benign#benign#damaging#neutral#damaging	PB004875#Pfam-B_4875#371#459#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	478,182289	NA	NA	NA	NA	117,78	195	0.4
Wm266-4	chr3	C	T	170009667	PASS	PRKCI	KPCI_HUMAN	ENSG00000163558	5584	missense_variant	p.T410I	p.T410I	ACC>ATC	exon13:c.1229C>T	NM_002740	mixed	.#probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#254#522#4#2	NA	NA	NA	NA	1	1	SOPHORETIN	NA	NA	NA	NA	31,182289	NA	NA	NA	NA	162,155	317	0.489
Wm266-4	chr7	C	A	138145436	PASS	TRIM24	TIF1A_HUMAN	ENSG00000122779	8805	missense_variant	p.A48D	p.A48D	GCC>GAC	exon1:c.143C>A	NM_015905,NM_003852	benign	tolerated#benign#benign#damaging#unknown#tolerated	NA	NA	NA	1	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	27,8	35	0.229
Wm35	chr9	G	A	133759812	PASS	ABL1	ABL1_HUMAN	ENSG00000097007	25	missense_variant	p.R712H,p.R731H	p.R712H	CGC>CAC	exon11:c.2135G>A,exon11:c.2192G>A	NM_005157,NM_007313	mixed	tolerated#probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	MOTIF@709@715@712		NA	1	NA	AS703569,AT9283,BAFETINIB,BOSUTINIB,DASATINIB,IMATINIB,NILOTINIB,PONATINIB,SARACATINIB,XL228	NA	NA	1	1,182289	NA	NA	NA	NA	1,4430	28,34	62	0.548
Wm35	chr9	C	A	133760723	PASS	ABL1	ABL1_HUMAN	ENSG00000097007	25	missense_variant	p.R1016S,p.R1035S	p.R1016S	CGC>AGC	exon11:c.3046C>A,exon11:c.3103C>A	NM_005157,NM_007313	mixed	tolerated#probably_damaging#benign#damaging#deleterious#tolerated	NA	NA	REGION@953@1130@1016		NA		NA	AS703569,AT9283,BAFETINIB,BOSUTINIB,DASATINIB,IMATINIB,NILOTINIB,PONATINIB,SARACATINIB,XL228	NA	NA	NA	NA	NA	NA	NA	NA	NA	70,6	76	0.079
Wm35	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA		NA		NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	79,115	194	0.593
Wm35	chr7	C	A	98547319	PASS	TRRAP	TRRAP_HUMAN	ENSG00000261023	8295	missense_variant	p.L1639M,p.L1657M	p.L1657M	CTG>ATG	exon35:c.4915C>A,exon36:c.4969C>A	NM_001244580,NM_003496	mixed	tolerated#possibly_damaging/probably_damaging#benign#damaging#deleterious#tolerated	PB006491#Pfam-B_6491#1589#1667#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	5,182289	NA	NA	NA	NA	326,77	404	0.191
Wm45-1	chr5	G	A	112178076	PASS	APC	APC_HUMAN	ENSG00000134982	324	missense_variant	p.S2244N,p.S2262N	p.S2262N	AGT>AAT	exon14:c.6731G>A,exon16:c.6785G>A,exon17:c.6785G>A	NM_001127511,NM_001127510,NM_000038	mixed	.#benign#benign#damaging#neutral#damaging	PF05956.6#APC_basic#2223#2579#0#0	NA	NA		NA	NA	1	NA	NA	NA	NA	NA	24,182289	NA	NA	NA	NA	0,96	96	1
Wm45-1	chr19	G	A	41743955	PASS	AXL	UFO_HUMAN	ENSG00000167601	558	missense_variant	p.G29D,p.G297D	p.G297D	GGC>GAC	exon4:c.86G>A,exon7:c.890G>A	NM_001699,NM_001278599,NM_021913	benign	tolerated#benign#benign#benign#unknown#tolerated	PF00041.16#fn3#226#321#5#4	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	15,182289	NA	NA	2,8231	NA	0,109	109	1
Wm45-1	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA	1	NA		NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	50,93	143	0.65
Wm45-1	chr17	A	C	41243840	PASS	BRCA1	BRCA1_HUMAN	ENSG00000012048	672	missense_variant	p.N1236K,p.N1189K	p.N1236K	AAT>AAG	exon10:c.3708T>G,exon9:c.3567T>G	NM_007297,NM_007300,NM_007294	benign	damaging#benign#benign#benign#neutral#tolerated	NA	NA	NA		NA	NA	1	NA	125	28897687	NA	NA	NA	NA	NA	NA	NA	80,141	221	0.638
Wm45-1	chr17	A	G	37672057	PASS	CDK12	CDK12_HUMAN	ENSG00000167258	51755	missense_variant	p.I948V	p.I948V	ATC>GTC	exon9:c.2842A>G	NM_016507,NM_015083	damaging	damaging#probably_damaging#benign#damaging#deleterious#tolerated	PF00069.20#Pkinase#727#1020#0#0	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	34,182289	NA	NA	NA	NA	0,180	180	1
Wm45-1	chr19	G	A	17950309	PASS	JAK3	JAK3_HUMAN	ENSG00000105639	3718	missense_variant	p.S473F	p.S473F	TCC>TTC	exon10:c.1418C>T	NM_000215	benign	tolerated#benign#benign#benign#neutral#tolerated	NA	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	10,7	17	0.412
Wm45-1	chr15	C	T	88476309	PASS	NTRK3	NTRK3_HUMAN	ENSG00000140538	4916	missense_variant	p.G600D,p.G608D	p.G608D	GGC>GAC	exon15:c.1799G>A,exon16:c.1823G>A	NM_002530,NM_001012338,NM_001243101	damaging	damaging#benign/possibly_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#538#824#1#1	NA	NA		NA	NA	NA	NA	NA	NA	NA	3,182289	64,182289	NA	NA	7,8231	NA	20,23	43	0.535
Wm45-1	chr6	C	T	117650610	PASS	ROS1	ROS1_HUMAN	ENSG00000047936	6098	splice_acceptor_variant	NA	NA	NA	exon33:c.5249-1G>A	NM_002944	damaging	.#.#.#damaging#.#.	NA	NA	NA		NA	1	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	102,105	207	0.507
Wm45-1	chr9	C	T	93637014	PASS	SYK	KSYK_HUMAN	ENSG00000165025	6850	missense_variant	p.P332L,p.P355L	p.P355L	CCC>CTC	exon8:c.995C>T,exon9:c.1064C>T	NM_001174168,NM_001135052,NM_003177,NM_001174167	damaging	tolerated#probably_damaging#damaging#damaging#deleterious#tolerated	NA	PS00107#PROTEIN_KINASE_ATP	REGION@260@370@355		NA	NA	NA	FOSTAMATINIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	1,38	39	0.974
Wm45-1	chr17	T	C	7578190	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	missense_variant	p.Y88C,p.Y61C,p.Y181C,p.Y220C	p.Y220C	TAT>TGT	exon2:c.263A>G,exon2:c.182A>G,exon5:c.542A>G,exon6:c.659A>G,exon6:c.542A>G	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00870.13#P53#95#289#11#9	NA	REGION@100@300@220,REGION@116@292@220,REGION@100@370@220,REGION@113@236@220,DNA_BIND@102@292@220		NA	NA	1	AD.P53-DC,EP-2101,MUTANT_P53_PEPTIDE_PULSED_DENDRITIC_CELL	NA	NA	215	257,182289	11903,182289	NA	NA	40,8231	33,4430	1,149	151	0.993
Wm852	chr8	C	T	57026125	PASS	MOS	MOS_HUMAN	ENSG00000172680	4342	missense_variant	p.M139I	p.M139I	ATG>ATA	exon1:c.417G>A	NM_005372	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00069.20#Pkinase#60#338#2#2	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	33,182289	NA	NA	NA	NA	15,88	103	0.854
Wm852	chr1	T	C	115256529	PASS	NRAS	RASN_HUMAN	ENSG00000213281	4893	missense_variant	p.Q61R	p.Q61R	CAA>CGA	exon3:c.182A>G	NM_002524	damaging	damaging#benign#damaging#damaging#unknown#damaging	PF00071.17#Ras#5#165#7#5	PS51421#RAS	NP_BIND@57@61@61	1	NA		NA	NA	120	11554290	798	1718,182289	2839,182289	378,8231	855,8231	1025,8231	53,4430	0,184	186	1
Wm852	chr9	G	T	93606379	PASS	SYK	KSYK_HUMAN	ENSG00000165025	6850	stop_gained	p.E67X	p.E67X	GAG>TAG	exon2:c.199G>T	NM_001174168,NM_001135052,NM_003177,NM_001174167	damaging	tolerated#.#.#damaging#deleterious#.	PF00017.19#SH2#15#92#40#22	NA	NA		NA	NA	NA	FOSTAMATINIB	NA	NA	NA	NA	8,182289	NA	NA	1,8231	NA	83,4	87	0.046
Wm852	chr17	G	A	7577559	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	missense_variant	p.S109F,p.S82F,p.S202F,p.S241F	p.S241F	TCC>TTC	exon3:c.326C>T,exon3:c.245C>T,exon6:c.605C>T,exon7:c.722C>T,exon7:c.605C>T	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00870.13#P53#95#289#11#9	PS00348#P53	DNA_BIND@102@292@241,REGION@241@248@241,REGION@100@370@241,REGION@100@300@241,REGION@116@292@241		NA	NA	1	AD.P53-DC,EP-2101,MUTANT_P53_PEPTIDE_PULSED_DENDRITIC_CELL	133	28934573	67	144,182289	11903,182289	NA	NA	40,8231	9,4430	0,87	87	1
Wm9	chr19	C	T	41744509	PASS	AXL	UFO_HUMAN	ENSG00000167601	558	missense_variant	p.P109S,p.P377S	p.P377S	CCA>TCA	exon5:c.325C>T,exon8:c.1129C>T	NM_001699,NM_001278599,NM_021913	benign	tolerated#benign#benign#damaging#neutral#tolerated	PF00041.16#fn3#335#418#5#4	NA	NA	NA	NA	1	NA	NA	NA	NA	NA	NA	5,182289	NA	NA	1,8231	NA	54,104	158	0.658
Wm9	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA	1	NA		NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	50,115	165	0.697
Wm9	chr19	G	A	15353735	PASS	BRD4	BRD4_HUMAN	ENSG00000141867	23476	missense_variant	p.H1049Y	p.H1049Y	CAC>TAC	exon14:c.3145C>T	NM_058243	benign	tolerated#benign#benign#damaging#neutral#tolerated	NA	NA	REGION@1047@1362@1049		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	62,86	148	0.581
Wm9	chr5	C	T	149449544	PASS	CSF1R	CSF1R_HUMAN	ENSG00000182578	1436	missense_variant	p.V468M	p.V468M	GTG>ATG	exon10:c.1402G>A,exon9:c.1402G>A	NM_005211,NM_001288705	mixed	damaging#probably_damaging#damaging#benign#neutral#tolerated	PF13927.1#Ig_3#399#489#0#0	NA	NA	NA	NA	1	NA	IMATINIB,DOVITINIB,DASATINIB,PLX3397,SUNITINIB	NA	NA	NA	NA	8,182289	NA	NA	NA	NA	56,17	73	0.233
Wm9	chr7	G	T	6431626	PASS	RAC1	RAC1_HUMAN	ENSG00000136238	5879	missense_variant	p.G60V	p.G60V	GGA>GTA	exon3:c.179G>T	NM_006908,NM_018890	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00071.17#Ras#5#178#35#24	PS51420#RHO	NP_BIND@57@61@60	1	NA	NA	NA	NA	NA	NA	NA	NA	50,182289	NA	NA	36,8231	NA	348,69	417	0.165
Wm9	chr10	G	A	43596005	PASS	RET	RET_HUMAN	ENSG00000165731	5979	missense_variant	p.D58N	p.D58N	GAC>AAC	exon2:c.172G>A	NM_020975,NM_020630	damaging	tolerated#probably_damaging#damaging#damaging#deleterious#damaging	NA	NA	NA		NA	1	NA	DOVITINIB,AMUVATINIB,AT9283,CABOZANTINIB,IMATINIB,LENVATINIB,MOTESANIB,REGORAFENIB,SORAFENIB,SUNITINIB,VANDETANIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	45,18	63	0.286
Wm9	chr12	C	T	10780284	PASS	STYK1	STYK1_HUMAN	ENSG00000060140	55359	missense_variant	p.E225K	p.E225K	GAA>AAA	exon7:c.673G>A	NM_018423	damaging	tolerated#probably_damaging#damaging#damaging#deleterious#tolerated	PF07714.12#Pkinase_Tyr#114#380#0#0	NA	NA	NA	NA		NA	NA	NA	NA	NA	NA	19,182289	NA	NA	NA	NA	119,188	307	0.612
Wm9	chr5	C	T	1264585	PASS	TERT	TERT_HUMAN	ENSG00000164362	7015	missense_variant	p.G926D	p.G926D	GGC>GAC	exon11:c.2777G>A	NM_198253	mixed	tolerated#benign#benign#damaging#deleterious#damaging	NA	NA	REGION@914@928@926	1	NA	NA	NA	IMETELSTAT,SODIUM_METAARSENITE	NA	NA	NA	NA	NA	NA	NA	NA	NA	145,157	302	0.52
Wm983	chr11	G	A	108205708	PASS	ATM	ATM_HUMAN	ENSG00000149311	472	missense_variant	p.G2675R	p.G2675R	GGA>AGA	exon55:c.8023G>A	NM_000051	damaging	tolerated#probably_damaging#damaging#damaging#deleterious#tolerated	NA	NA	NA		NA	NA	1	BMN673,E7449,NIRAPARIB,OLAPARIB,RUCAPARIB,VELIPARIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	0,243	243	1
Wm983	chr7	A	T	140453136	PASS	BRAF	BRAF_HUMAN	ENSG00000157764	673	missense_variant	p.V600E	p.V600E	GTG>GAG	exon15:c.1799T>A	NM_004333	damaging	damaging#probably_damaging#benign#damaging#deleterious#damaging	PF07714.12#Pkinase_Tyr#457#714#7#7	NA	NA		NA	1	NA	GDC-0973,GSK_2118436,ARQ736,CHIR-265,DABRAFENIB,GSK2118436,LGX818,PLX3603,RAF265,REGORAFENIB,RO5212054,SORAFENIB,VEMURAFENIB,XL281,ZELBORAF,MEK162,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TRAMETINIB	132	113488022	17819	18463,182289	18905,182289	3332,8231	3762,8231	3868,8231	306,4430	112,126	238	0.529
Wm983	chr9	G	A	21971017	PASS	CDKN2A	CD2A1_HUMAN	ENSG00000147889	1029	missense_variant	p.P114L	p.P114L	CCC>CTC	exon2:c.341C>T	NM_001195132,NM_000077	damaging	damaging#probably_damaging#.#damaging#.#tolerated	NA	PS50297#ANK_REP_REGION	NA		NA	NA	1	BAY1000394,LEE011,LY2835219,PD_0332991	133	121913386	18	21,182289	NA	8,8231	9,8231	NA	5,4430	0,145	145	1
Wm983	chr4	T	A	55980309	PASS	KDR	VGFR2_HUMAN	ENSG00000128052	3791	missense_variant	p.E261V	p.E261V	GAA>GTA	exon6:c.782A>T	NM_002253	benign	tolerated#benign#benign#benign#neutral#tolerated	PF07686.12#V-set#225#324#8#6	NA	NA		NA	NA	NA	NA	NA	NA	NA	NA	16,182289	NA	NA	1,8231	NA	197,179	378	0.476
Wm983	chr12	C	A	25368441	PASS	KRAS	RASK_HUMAN	ENSG00000133703	3845	missense_variant	p.L168F	p.L168F	TTG>TTT	exon5:c.504G>T	NM_033360	mixed	damaging#benign#benign#damaging#deleterious#tolerated	NA	PS51421#RAS	REGION@166@185@168		NA	1	NA	CETUXIMAB,ERLOTINIB,EVEROLIMUS,GDC-0973,GEFITINIB,REOLYSIN,MEK162,PANITUMUMAB,PD-325901,PIMASERTIB,RAFAMETINIB,SELUMETINIB,TEMSIROLIMUS,TRAMETINIB,RAS_PEPTIDE_CANCER_VACCINE,VANDETANIB	NA	NA	NA	NA	NA	NA	NA	NA	NA	405,15	422	0.036
Wm983	chr17	G	A	7577105	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	missense_variant	p.P146L,p.P119L,p.P239L,p.P278L	p.P278L	CCT>CTT	exon4:c.437C>T,exon4:c.356C>T,exon7:c.716C>T,exon8:c.833C>T,exon8:c.716C>T	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	damaging	damaging#probably_damaging#damaging#damaging#neutral#damaging	PF00870.13#P53#95#289#11#9	NA	DNA_BIND@102@292@278,REGION@100@370@278,REGION@273@280@278,REGION@116@292@278,REGION@100@300@278,REGION@256@294@278		NA	NA	1	AD.P53-DC,EP-2101,MUTANT_P53_PEPTIDE_PULSED_DENDRITIC_CELL	NA	NA	56	201,182289	11903,182289	1,8231	2,8231	40,8231	4,4430	0,138	138	1
Wm983	chr17	G	A	7577106	PASS	TP53	P53_HUMAN	ENSG00000141510	7157	missense_variant	p.P146S,p.P119S,p.P239S,p.P278S	p.P278S	CCT>TCT	exon4:c.436C>T,exon4:c.355C>T,exon7:c.715C>T,exon8:c.832C>T,exon8:c.715C>T	NM_001276761,NM_001126112,NM_001126113,NM_001276695,NM_001276697,NM_001276696,NM_000546,NM_001126118,NM_001126116,NM_001126117,NM_001126114,NM_001126115,NM_001276699,NM_001276698,NM_001276760	damaging	damaging#probably_damaging#damaging#damaging#deleterious#damaging	PF00870.13#P53#95#289#11#9	NA	DNA_BIND@102@292@278,REGION@100@370@278,REGION@273@280@278,REGION@116@292@278,REGION@100@300@278,REGION@256@294@278		NA	NA		AD.P53-DC,EP-2101,MUTANT_P53_PEPTIDE_PULSED_DENDRITIC_CELL	NA	NA	49	201,182289	11903,182289	1,8231	2,8231	40,8231	4,4430	0,138	138	1
